Group EI- (N = 302) | Group EI+ (N = 39) | p | |
---|---|---|---|
Constitutional characteristics | |||
Gender: Male | 56.3% (170) | 53.9% (21) | 0.77 |
Atopy in family* | 37.1% (112) | 48.7% (19) | 0.16 |
Clinical atopy† | 19.9% (60) | 15.4% (6) | 0.67** |
Personal atopy‡ (61 missing data) | 25.7% (64) | 61.3% (19) | <0.001 |
Behavioural characteristics | |||
Training track | |||
Bakery | 36.8% (111) | 28.2% (11) | |
Pastry making | 23.8% (72) | 38.5% (15) | 0.14 |
Hairdressing | 39.4% (119) | 33.3% (13) | |
Tobacco usage status | |||
Non smoker | 48.0% (145) | 56.4% (22) | |
Current smoker | 48.7% (147) | 38.5% (15) | 0.36** |
Past smoker | 3.3% (10) | 5.1% (2) | |
Baseline FEV1§ | |||
>80.8% | 86.1% (260) | 84.6% (33) | |
>76.0% and <80.7% | 8.9% (27) | 7.7% (3) | 0.70** |
<76.0% | 5.0% (15) | 7.7% (3) | |
MBC test | |||
Airways responsiveness | |||
MBC- | 88.1% (266) | 69.2% (27) | |
MBC+ ≥15 and <20% (% (n)) | 7.3% (22) | 18.0% (7) | <0.01** |
MBC+ ≥20% (% (n)) | 4.6% (14) | 12.8% (5) | |
Rrs4-16 increase (%) (mean (sd)) | |||
<42.4% | 88.1% (266) | 79.5% (31) | |
>42.4% and <54.6% | 7.0% (21) | 7.7% (3) | 0.13** |
>54.6% | 5.0% (15) | 12.8% (5) | |
Clinical indicators of airway inflammation | |||
Rhinoconjunctivitis-like symptoms|| | 8.6% (26) | 15.4% (6) | 0.24** |
Asthma-like symptoms¶ | 3.6% (11) | 7.7% (3) | 0.21** |
Quantitative indicators of airway inflammation | |||
FENO in ppb (median (first-third quartiles)) | 12.0 (8.7-16.6) | 50.8 (20.4-69.5) | <0.0001†† |
FENO in percent predicted# | |||
<140% | 93.4% (282) | 33.3% (13) | |
>140% and <225% | 6.6% (20) | 12.8% (5) | <0.001** |
>225% | 0 | 53.9% (21) | |
Eosinophil count in nasal fluid lavage | |||
<1% | 93.1% (281) | 33.3% (13) | |
>1% and <14% | 7.0% (21) | 5.1% (2) | <0.001** |
>14% | 0 | 61.5% (24) |